Brief: China Resources Pharmaceutical Says Unit Received Approval From China Securities Regulatory Commission For Public Issuance Of Corporate Bonds
21/01/2022 15:06
Jan 21 (Reuters) - China Resources Pharmaceutical Group Ltd
3320.HK :
* UNIT HAS RECEIVED AN APPROVAL FROM CHINA SECURITIES
REGULATORY
COMMISSION FOR PUBLIC ISSUANCE OF CORPORATE BONDS
* CSRC APPROVED PROPOSED PUBLIC ISSUANCE OF CORPORATE BONDS
BY
UNIT IN AMOUNT OF NOT MORE THAN RMB10 BILLION
Source text for Eikon: ID:nHKS40l9DN
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals